Genor Biopharma Co., Ltd.

3 articles with Genor Biopharma Co., Ltd.

• Ascentage Pharma Announces Strategic Collaboration with Genor Biopharma

  12/19/2018

  Collaboration to evaluate combination of APG-115, Ascentage's MDM2-p53 inhibitor and genolimzumab, Genor's anti-PD-1 monoclonal antibody in solid tumors and blood cancers

• CBT Pharmaceuticals Receives First Australian Ethics Approval to Initiate APOLLO-1 Phase 1/2 Clinical Trial for Hepatocellular and Renal Cell Carcinoma

  8/8/2018

  CBT Pharmaceuticals (CBT), a U.S. and China-based innovative biopharmaceutical company committed to becoming a leader in the discovery and development of oncology combination therapies, today announced the receipt of ethics approval from the Bellberry Human Research Ethics Committee (HREC) in Australia for its planned APOLLO-1 clinical trial.

• Genor Biopharma, Walvax’s, Partners With Mabspace Biosciences To Discover And Develop Novel Antibody Therapeutics

  5/21/2015